Evaluation of primary urinary tract infection in infants

Wan, et al evaluated 95 infants who presented with a urinary tract infection.

They reviewed the clinical and laboratory findings as well as the diagnosis and treatment. This study is important since urinary tract infection is one of the most common causes of unexplained fevers in infants with an overall reported prevalence of approximately 10%.

All the patients in this study underwent renal ultrasonography, voiding cystourethrogram, and a DMSA scan during the hospitalization before treatment. Their treatment consisted of 2-4 weeks of appropriate antibiotic therapy when pyelonephritis was diagnosed. These patients then underwent a second DMSA scan 6 months after therapy.

The group found that the main symptom of these infants with a UTI was fever. High white blood cell count was not necessarily present and urinalysis was also imperfect for diagnosing UTI's. They also found they colony count from urine cultures in kidney ultrasonography was not efficacious in terms of predicting the occurrence of pyelonephritis. They found that intravenous antibiotic for one week followed by 3 weeks of the same oral antibiotic provided good prophylaxis for uncomplicated pyelonephritis.

The group concluded that 4 weeks of antibiotic treatment resulted in a good recovery from pyelonephritis of infants with primary UTI. They also feel that a voiding cystourethrogram along with a DMSA study including ultrasonography should be performed in infants who come in with a diagnosis of UTI. A c- reactive protein level may have been more helpful than a white blood cell count in these infants. The results of the DMSA scan may lead one to correct vesicotueral reflux if it is present. In the absence of vesicotueral reflux, what would one do with a DMSA scan that was positive for renal scarring 6 months after therapy was instituted. Further investigations with a larger cohort may help clarify this dilemma.

Kong-Sang Won, Chih-Kuang Liu, Li-Hui Chen.

Nephrology 12(2): 178-181, April 2007

By Pasquale Casale, MD

http://www.urotoday.com

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Engineered SNIPRs transform CAR T-cell precision for safer cancer therapy